SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037296
Filing Date
2023-08-02
Accepted
2023-08-02 17:02:32
Documents
86
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20230630.htm   iXBRL 10-Q 4256343
2 EX-31.1 inva-ex31_1.htm EX-31.1 16178
3 EX-31.2 inva-ex31_2.htm EX-31.2 16181
4 EX-32 inva-ex32.htm EX-32 26901
  Complete submission text file 0000950170-23-037296.txt   17625389

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20230630_cal.xml EX-101.CAL 100591
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20230630.xsd EX-101.SCH 99135
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20230630_lab.xml EX-101.LAB 737373
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20230630_pre.xml EX-101.PRE 632784
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20230630_def.xml EX-101.DEF 492017
80 EXTRACTED XBRL INSTANCE DOCUMENT inva-20230630_htm.xml XML 4054754
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 231136764
SIC: 2834 Pharmaceutical Preparations